Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

INTRODUCTION: New target-specific oral anticoagulants may have benefits, such as shorter hospital length of stay, compared to warfarin in patients with nonvalvular atrial fibrillation (NVAF). This study aimed to assess, among patients with NVAF, the effect of rivaroxaban versus warfarin on health ca...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Adv Ther
Päätekijät: Laliberté, François, Cloutier, Michel, Crivera, Concetta, Nelson, Winnie W., Olson, William H., Schein, Jeffrey, Vanderpoel, Julie, Germain, Guillaume, Lefebvre, Patrick
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2015
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376962/
https://ncbi.nlm.nih.gov/pubmed/25784509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0189-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia